4 completed, 2 recruiting, 1 unknown. 3 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow Bone Disease, Metabolic: new trials by email Literature Review of Bone Disease, Metabolic trials Research Report on Bone Disease, Metabolic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA) Glucose-dependent Insulinotropic Polypeptide (GIP) - Bone Disease, Metabolic, Diabetes Mellitus, Type 2 | Not applicable | Completed | Esbjerg Hospital - University Hospital of Southern Denmark | 13 | 2025-11-10 | 2026-10-01 |
| Elucidating the Minimal Effective Dose of Prunes for Bone Health in Postmenopausal Women Prune - Bone Disease, Metabolic | Not applicable | Recruiting | San Diego State University | 200 | 2024-03-15 | 2026-07-01 |
| Diagnosis of Osteogenesis Imperfecta in Children Zoledronic Acid - Bone Disease, Metabolic | Unknown | Assiut University | 40 | 2017-06-01 | 2017-05-30 | |
| Metabolic Profile of Bone in Professional Athletes blood and saliva tests - Bone Disease, Metabolic, Physical Activity | Recruiting | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 200 | 2016-02-04 | 2025-09-11 | |
| Efficacy of Potassium Citrate in the Treatment of Postmenopausal Osteopenia Potassium citrate, Placebo, Vitamin D3 - Osteopenia, Bone Disease, Metabolic | Not applicable | Completed | Istituto Ortopedico Rizzoli | 40 | 2015-09-01 | 2019-11-12 |
| Electromagnetic Treatment For Bone Loss After Forearm Fracture Pulsing electromagnetic field (PEMF) - Bone Disease, Metabolic, Osteopenia | Phase 1 / Phase 2 | Completed | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 80 | 2003-11-01 | 2015-12-23 |
| Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant Disodium pamidronate, Placebo - Bone Disease, Metabolic | Phase 4 | Completed | Hospital Clinic of Barcelona | 79 | 2000-12-01 | 2008-04-14 |
Bone Diseases, Metabolic (7) · Diabetes Mellitus, Type 2 (1) · Motor Activity (1) · Obesity (1) · Osteoporosis (1)
Bone Diseases (7) · Metabolic Diseases (7) · Musculoskeletal Diseases (7) · Nutritional and Metabolic Diseases (7) · Behavior (1) · Body Weight (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Nutrition Disorders (1) · Overnutrition (1) · Overweight (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Blood Specimen Collection (1) · Calcium Carbonate (1) · Cholecalciferol (1) · Incretins (1) · Pamidronate (1) · Potassium Citrate (1) · Zoledronic Acid (1)
Assiut University (1) · Esbjerg Hospital - University Hospital of Southern Denmark (1) · Hospital Clinic of Barcelona (1) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio (1) · Istituto Ortopedico Rizzoli (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1) · San Diego State University (1)
Italy (2) · United States (2) · Denmark (1) · Egypt (1) · Spain (1)
Joseph A. Spadaro, PhD (1) · Miquel Navasa, Dr (1) · Nicola Baldini, MD, Prof. (1) · Shirin Hooshmand, PhD (1)
PMID 11685427, PMID 15018482, PMID 15220316, PMID 16648882, PMID 18404382, PMID 18843680, PMID 20632739, PMID 20878421, PMID 22407910, PMID 22475109, PMID 22628324, PMID 22848709, PMID 23647316, PMID 24433517, PMID 25058327, PMID 25158976, PMID 25368616, PMID 25872144, PMID 26306846, PMID 26718191, PMID 27669735, PMID 30213095, PMID 7747001